Related Experiment Video
Updated: Aug 25, 2026

Cecal Ligation Puncture Procedure
Published on: May 7, 2011
Coagulation in sepsis: all bugs bite equally
Marcel Levi1, Tom van der Poll
1Department of Medicine, Academic Medical Center, University of Amsterdam, The Netherlands. m.m.levi@amc.uva.nl
Abstract:
Sepsis almost invariably leads to hemostatic abnormalities, ranging from insignificant laboratory changes to severe disseminated intravascular coagulation. There is compelling evidence from clinical and experimental studies that disseminated intravascular coagulation is involved in the pathogenesis of microvascular dysfunction and contributes to organ failure. Data from the PROWESS phase III clinical trial of recombinant activated protein C in patients with severe sepsis confirm this notion and demonstrate that the vast majority of patients with severe sepsis have increased markers for systemic coagulation activation, decreased physiological anticoagulant proteins and depressed fibrinolysis. There is no correlation between the type of microorganism that has caused the infection and the presence or severity of the coagulation disorder.
Insights
Sepsis frequently causes blood clotting abnormalities, including disseminated intravascular coagulation (DIC), which contributes to organ failure. These coagulation issues are common in severe sepsis regardless of the infecting microorganism.
Area of Science:
- Hematology
- Critical Care Medicine
- Pathophysiology
Background:
- Sepsis commonly induces hemostatic abnormalities, from minor lab alterations to severe disseminated intravascular coagulation (DIC).
- Evidence suggests DIC plays a role in sepsis-induced microvascular dysfunction and organ failure.
- The PROWESS trial confirmed widespread coagulation system activation in severe sepsis.
Discussion:
- Patients with severe sepsis exhibit elevated markers of systemic coagulation activation.
- Physiological anticoagulant proteins are decreased in severe sepsis patients.
- Fibrinolysis is depressed in the context of severe sepsis.
Key Insights:
- Disseminated intravascular coagulation (DIC) is a significant complication of sepsis, impacting microcirculation and organ function.
- Coagulation disorders in sepsis are not correlated with the specific causative microorganism.
- Therapeutic strategies targeting coagulation pathways may be crucial for sepsis management.
Outlook:
- Further research into the precise mechanisms linking DIC and organ failure in sepsis is warranted.
- Investigating novel anticoagulant or procoagulant therapies could improve sepsis outcomes.
- Understanding the heterogeneity of coagulation abnormalities in sepsis may guide personalized treatment approaches.
Related Concept Videos
Determinants of Bacterial Pathogenicity and Virulence
Rocky Mountain Spotted Fever
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Plague
